# Study of X0002 Following Escalating Single and Multiple Doses Administered as Topical Application in Healthy Volunteers

> **NCT02794740** · PHASE1 · COMPLETED · sponsor: **Tianjin XinChen-Techfields Pharma Co., LTD.** · enrollment: 34 (actual)

## Conditions studied

- Osteoarthritis

## Interventions

- **DRUG:** X0002
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02794740
- **Lead sponsor:** Tianjin XinChen-Techfields Pharma Co., LTD.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06
- **Primary completion:** 2017-03
- **Final completion:** 2017-03-29
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2018-09-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02794740

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02794740, "Study of X0002 Following Escalating Single and Multiple Doses Administered as Topical Application in Healthy Volunteers". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02794740. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*